… This grant builds upon the research from a prior grant: The Role of LRRK2 in … cell death in PD (the substantia nigra) releases dopamine into another brain region called the striatum. These two … of these different biological situations. Relevance to Diagnosis/Treatment of Parkinson’s Disease:                 …

… Study Rationale: In previous research, we demonstrated that the protein tumor necrosis … impact of TNFR2 activity on disease progression. Impact on Diagnosis/Treatment of Parkinson’s Disease: This study could … we will develop the experimental TNFR2-blocking drug into a clinical product with the goal to ultimately evaluate …

… people were considered “sporadic” cases. However, novel research suggests that common non-disease-causing variants … in samples from our Luxembourgish PD cohort. Impact on Diagnosis/Treatment of Parkinson’s disease:  If successful, … the next steps would involve developing mito-PRSs into tools that could be used in clinical trials to better …

… for alpha-synuclein. Discovery of such markers would aid in diagnosis and allow the assessment of new therapies that … tau-based disorders and from people with PD. Impact on Diagnosis/Treatment of Parkinson’s disease:  We are … Research Grant …

… comparable to that of PRE-084 and to translate this dose into an equivalent dose for human use. Study Design: We will … ligand from binding to brain sigma-1 receptors. Impact on Diagnosis/Treatment of Parkinson’s Disease:              The … will accelerate the translation of pre-clinical findings into the first clinical trial of ANAVEX2-73 as a potential …

… activate Parkin. We will introduce these mutations into the cells that make Parkin proteins. We will see which … models to see if results can be replicated. Impact on Diagnosis/Treatment of Parkinson's disease: First, these … that activate Parkin in human cells will be introduced into a pre-clinical model of Parkinson's disease for further …